Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT

Abstract Propensity score matching evaluates the treatment incidence of radiation-induced pneumonitis (RP) and secondary cancer risk (SCR) after intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for breast cancer patients. Of 32 patients treated with IMRT and 58 who...

Full description

Bibliographic Details
Main Authors: Pei-Ju Chao, Hsiao-Fei Lee, Jen-Hong Lan, Shih-Sian Guo, Hui-Min Ting, Yu-Jie Huang, Hui-Chun Chen, Tsair-Fwu Lee
Format: Article
Language:English
Published: Nature Portfolio 2017-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-14145-x
_version_ 1818844045347127296
author Pei-Ju Chao
Hsiao-Fei Lee
Jen-Hong Lan
Shih-Sian Guo
Hui-Min Ting
Yu-Jie Huang
Hui-Chun Chen
Tsair-Fwu Lee
author_facet Pei-Ju Chao
Hsiao-Fei Lee
Jen-Hong Lan
Shih-Sian Guo
Hui-Min Ting
Yu-Jie Huang
Hui-Chun Chen
Tsair-Fwu Lee
author_sort Pei-Ju Chao
collection DOAJ
description Abstract Propensity score matching evaluates the treatment incidence of radiation-induced pneumonitis (RP) and secondary cancer risk (SCR) after intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for breast cancer patients. Of 32 patients treated with IMRT and 58 who received VMAT were propensity matched in a 1:1 ratio. RP and SCR were evaluated as the endpoints of acute and chronic toxicity, respectively. Self-fitted normal tissue complication probability (NTCP) parameter values were used to analyze the risk of RP. SCRs were evaluated using the preferred Schneider’s parameterization risk models. The dosimetric parameter of the ipsilateral lung volume receiving 40 Gy (IV40) was selected as the dominant risk factor for the RP NTCP model. The results showed that the risks of RP and NTCP, as well as that of SCR of the ipsilateral lung, were slightly lower than the values in patients treated with VMAT versus IMRT (p ≤ 0.01). However, the organ equivalent dose and excess absolute risk values in the contralateral lung and breast were slightly higher with VMAT than with IMRT (p ≤ 0.05). When compared to IMRT, VMAT is a rational radiotherapy option for breast cancer patients, based on its reduced potential for inducing secondary malignancies and RP complications.
first_indexed 2024-12-19T05:07:31Z
format Article
id doaj.art-0a87b15e8e394bbbb55579ebb17264a6
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T05:07:31Z
publishDate 2017-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-0a87b15e8e394bbbb55579ebb17264a62022-12-21T20:34:53ZengNature PortfolioScientific Reports2045-23222017-10-01711910.1038/s41598-017-14145-xPropensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMATPei-Ju Chao0Hsiao-Fei Lee1Jen-Hong Lan2Shih-Sian Guo3Hui-Min Ting4Yu-Jie Huang5Hui-Chun Chen6Tsair-Fwu Lee7Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungMedical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungMedical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungMedical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungMedical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungDepartment of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, KaohsiungDepartment of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, KaohsiungMedical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Applied Sciences, KaohsiungAbstract Propensity score matching evaluates the treatment incidence of radiation-induced pneumonitis (RP) and secondary cancer risk (SCR) after intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for breast cancer patients. Of 32 patients treated with IMRT and 58 who received VMAT were propensity matched in a 1:1 ratio. RP and SCR were evaluated as the endpoints of acute and chronic toxicity, respectively. Self-fitted normal tissue complication probability (NTCP) parameter values were used to analyze the risk of RP. SCRs were evaluated using the preferred Schneider’s parameterization risk models. The dosimetric parameter of the ipsilateral lung volume receiving 40 Gy (IV40) was selected as the dominant risk factor for the RP NTCP model. The results showed that the risks of RP and NTCP, as well as that of SCR of the ipsilateral lung, were slightly lower than the values in patients treated with VMAT versus IMRT (p ≤ 0.01). However, the organ equivalent dose and excess absolute risk values in the contralateral lung and breast were slightly higher with VMAT than with IMRT (p ≤ 0.05). When compared to IMRT, VMAT is a rational radiotherapy option for breast cancer patients, based on its reduced potential for inducing secondary malignancies and RP complications.https://doi.org/10.1038/s41598-017-14145-x
spellingShingle Pei-Ju Chao
Hsiao-Fei Lee
Jen-Hong Lan
Shih-Sian Guo
Hui-Min Ting
Yu-Jie Huang
Hui-Chun Chen
Tsair-Fwu Lee
Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
Scientific Reports
title Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
title_full Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
title_fullStr Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
title_full_unstemmed Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
title_short Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT
title_sort propensity score matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with imrt vmat
url https://doi.org/10.1038/s41598-017-14145-x
work_keys_str_mv AT peijuchao propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT hsiaofeilee propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT jenhonglan propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT shihsianguo propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT huiminting propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT yujiehuang propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT huichunchen propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat
AT tsairfwulee propensityscorematchedevaluationoftheincidenceofradiationpneumonitisandsecondarycancerriskforbreastcancerpatientstreatedwithimrtvmat